International Centre for Diarrhoeal Disease Research, Bangladesh: Cholera trials

The registry lists 16 Cholera studies with International Centre for Diarrhoeal Disease Research, Bangladesh as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 4Phase 3 7No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Cholera Control by Case-area Targeted Interventions (CATIs)RecruitingNCT07685574Not applicable
• Co-administration Study of OCV, TCV and MRNot yet recruitingNCT05771779Phase 3
• Immunogenicity of Co-administered Oral Polio Vaccine and Oral Cholera VaccineStatus unknownNCT03581734Phase 3
• Safety and Immunogenicity of Locally Manufactured New (HL-OCV) Oral Cholera VaccineCompletedNCT02823899Phase 1/2
• Safety and Immunogenicity of Locally Manufactured Oral Cholera VaccineCompletedNCT02742558Phase 2
• Cholera Vaccine Investment Strategy in BangladeshCompletedNCT02727855
• Single Dose Oral Cholera Vaccine Study in Dhaka, BangladeshCompletedNCT02027207Phase 3
• Oral Cholera Vaccine Delivery in Rural BangladeshCompletedNCT01811771Not applicable
• Introduction of Cholera Vaccine in BangladeshCompletedNCT01339845Not applicable
• Studies of Immune Responses to Orally Administered Vaccines in Developing CountryCompletedNCT01019083Phase 1/2
• Ciprofloxacin Multiple Dose for Adult CholeraCompletedNCT00741052Phase 3
• Efficacy of Benefiber-Added, Reduced-Osmolarity WHO-ORS in the Treatment of Cholera in AdultsCompletedNCT00672308Phase 2
• Effect of Probiotic on Immunogenicity of Oral Cholera VaccineCompletedNCT00464867Not applicable
• Single Dose Azithromycin in the Treatment of Adult CholeraCompletedNCT00229944Phase 3
• Zinc Supplementation in Cholera PatientsCompletedNCT00226616Phase 3
• Single Dose Ciprofloxacin in the Treatment of Childhood Cholera:Randomized Controlled Clinical TrialCompletedNCT00142272Phase 3